Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.
Research on medications to treat alcohol problems has flourished in the last 5 years. Whereas before this time most projects focused on withdrawal agents, at least equal interest has now extended to drugs that may directly reduce urge to drink. The most promising medications in this regard are the opiate antagonists and acamprosate. Considerable attention has also been devoted to serotonergic agents. As aids to detoxification, pharmacologic agents that affect the multiple neural systems disrupted by acute alcohol withdrawal remain under active investigation. Significant progress is also being made in identifying medications to assist alcoholics suffering collateral psychopathology, especially depression and anxiety based disorders. Unfortunately, fewer gains have been realized in the development of medications to assist patients simultaneously dependent on both alcohol and illicit drugs. Also, research to develop amethystic agents remains in its very early stages.
Litten
R Z
RZ
Allen
J
J
Fertig
J
J
D000077443:Acamprosate; D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy* / Q000523:psychology; D000437:Alcoholism / Q000523:psychology / Q000534:rehabilitation*; D001008:Anxiety Disorders / Q000523:psychology / Q000534:rehabilitation; D015897:Comorbidity; D003866:Depressive Disorder / Q000523:psychology / Q000534:rehabilitation; D006801:Humans; D009042:Motivation; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D013654:Taurine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D011619:Psychotropic Drugs; D013654:Taurine; D000077443:Acamprosate